Interleukin-18 modulates immune responses induced by HIV-1 Nef DNA prime/protein boost vaccine

Vaccine

Volumn 19, Issue 1, 2000, Pages 95-102

  Billaut Mulot, Odile ^a   Idziorek, Thierry ^a   Ban, Elisabeth ^a   Kremer, Laurent ^a   Dupré, Loic ^a   Loyens, Marc ^a   Riveau, Gilles ^a   Locht, Camille ^a   Capron, André ^a   Bahr, George M ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

DNA vaccination; HIV; IL 18

Indexed keywords

DNA VACCINE; INTERLEUKIN 18; M PROTEIN; NEF PROTEIN; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; FEMALE; GENE TARGETING; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; TH1 CELL;

AIDS VACCINES; ANIMALS; ANTIBODY FORMATION; DNA, VIRAL; FEMALE; GENE PRODUCTS, NEF; HIV-1; IMMUNITY, CELLULAR; IMMUNIZATION, SECONDARY; INTERLEUKIN-18; MICE; MICE, INBRED BALB C; PLASMIDS; RECOMBINANT PROTEINS; VACCINES, DNA; VIRAL PROTEINS;

EID: 18144441150     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00157-2     Document Type: Article

References (28)

1. Cohen A.D., Boyer J.D., Weiner D.B. Modulating the immune response to genetic immunization. FASEB J. 12:1998;1611-1626.
2. Asakura Y., Lundholm P., Kjerrström A., Benthin R., Lucht E., Fukushima J., et al. DNA-plasmids of HIV-1 induces systemic and mucosal immune responses. J. Biol. Chem. 380:1999;375-379.
3. Barnett S.W., Rajasekar S., Legg H., Doe B., Fuller D.H., Haynes J.R., et al. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit. Vaccine. 15:1997;869-873.
4. Raz E., Watanabe A., Baird S.M., Eisenberg R.A., Parr T.B., Lotz M., et al. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc. Natl. Acad. Sci. USA. 90:1993;4523-4527.
5. Kim J.J., Trivedi N.N., Nottingham L.K., Morrison L., Tsai A., Hu Y., et al. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur. J. Immunol. 28:1998;1089-1103.
6. Okamura H., Nagata K., Komatsu T., Tanimono T., Nukata Y., Tanabe F., et al. A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect. Immun. 63:1995;3966-3972.
7. Robert-Guroff M., Popovic M., Gartner S., Markham P., Gallo R.C., Reitz M.S. Structure and expression of Tat, Rev and Nef specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J. Virol. 64:1990;3391-3398.
8. Miller M.D., Warmerdam M.T., Gaston I., Greene W.C., Feinberg M.B. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179:1994;101-103.
9. Chowers M.Y., Spina C.A., Kwoh T.J., Fitch J.S., Richman D.D., Cuatelli J.C. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J. Virol. 68:1994;2906-2914.
10. Kremer L., Dupré L., Wolowczuk I., Locht C. In vivo immunomodulation following intradermal injection with DNA encoding IL-18. J. Immunol. 163:1999;3226-3231.
11. Laemmli U.K. Cleavage of stuctural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680.
12. Manthorpe M., Cornefer-Jensen F., Hartikka J., Felgner J., Rundell A., Margalith, et al. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum. Gene Ther. 4:1993;419-431.
13. Fuller D.H., Haynes J.R. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune response in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res. and Hum. Retroviruses. 10:1994;1433-1441.
14. Asakura Y., Hamajima J., Mohri H., Okubo T., Okuda K. Induction of HIV-1 Nef cytotoxic T lymphocytes by Nef-expressing DNA vaccine. Amer. J. Hematol. 53:1996;116-117.
15. Moynier M., Kavsan V., Gales C., Montagnier L., Bahraoui E. Characterization of humoral immune responses induced by immunization with plasmid DNA expressing HIV-1 Nef accessory protein. Vaccine. 16:1998;1523-1530.
16. Hinkula J., Lundholm P., Wahren B. Nucleic acid vaccination with HIV regulatory gene: a combination of HIV-1 genes in separate plasmids induces strong immune responses. Vaccine. 15:1997;874-878.
17. Agadjanyan M.G., Trivedi N.N., Kudchodkar S., Bennett M., Levine W., Lin A., et al. An HIV type 2 DNA vaccine induces cross-reactive immune responses against HIV type 2 and SIV. AIDS Res. and Hum. Retroviruses. 13:1997;1561-1572.
18. Richmond J.F.L., Lu S., Santoro J.C., Weng J., Hu S.L., Montefiori D.C., Robinson H.L. Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody eliced by DNA priming and protein boosting. J. Virol. 72:1998;9092-10000.
19. Letvin N.L., Montefiori D.C., Yasutomi Y., Perry H.C., Davies M.E., Lekutis C., et al. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc. Natl. Acad. Sci. USA. 94:1997;9378-9383.
20. Hanke T., Blanchard T.J., Schneider J., Hannan C.M., Becker M., Gilbert S.C., et al. Enhancement of MHC class I-restricted peptide-specific T-cell induction by DNA prime/MVA boost vaccination regime. Vaccine. 16:1998;439-445.
21. Fuller D.H., Simpson L., Cole K.S., Clements J., Panicali D.L., Montelaro R.C., et al. Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vactors supresses virus burden in rherus macaques challenged with a heterologous SIV. Immunol. Cell Biol. 75:1997;389-396.
22. Richmond J.F.L., Mustafa F., Santoro J.C., Weng J., O'Connell M., Fenyö E.M., et al. Screening of HIV-1 Env glycoproteins for ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting. J. Virol. 230:1997;265-274.
23. Kent S.J., Zhao A., Best S.J., Chandler J.D., Boyle D.B., Ramshaw I.A. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol. 72:1998;10180-10188.
24. Caver T.E., Lockey T.D., Srinivas R.V., Webster R.G., Hurwitz J.L. A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation. Vaccine. 17:1997;1567-1572.
25. Kim J.J., Ayyavoo V., Bagarazzi M.L., Chattergoon M.A., Dang K., et al. In vivo engineering of a cellular immune response by co-administration of IL12 expression vector with a DNA immunogen. J. Immunol. 158:1997;816-826.
26. Kohno K., Kataoka J., Ohtsuki T., Suemoto Y., Okamoto I., Usui M., et al. IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of TH1 but not TH2 cells and exerts its effect independently of IL-12. J. Immunol. 158:1997;1541-1550.
27. Conry R.M., Wildera G., Lobuglio A.F., Fuller J.T., Moore S.E., Barlow D.L., et al. Selected strategies to augment polynucleotide immunization. Gene Ther. 3:1996;67-74.
28. Barouch D.H., Santra S., Steenbeke T.D., Zheng X.X., Perry H.C., Davies M.E., et al. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J. Immunol. 161:1998;1875-1882.